CSRXP ANALYSIS: BIG PHARMA SPENT TAX WINDFALL ON PROFITS, NOT R&D

12-10-2019 Press Release

Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times More Than Increased Investment in ‘Innovation’ For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released an analysis Tuesday that found brand name prescription drug manufacturers used a windfall from the Tax Cuts and Jobs […]

CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE

11-22-2019 Press Release

Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers for Rising Prices and Want Congress to Pass Bipartisan Reforms Before Year End For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday on a new survey conducted in five top 2020 […]

CSRxP: Policymakers Must Remove Big Pharma Carveout in USMCA

10-23-2019 Press Release

Washington Can Put Patients First By Amending Trade Provision That Would Hamper Generic and Biosimilar Competition For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) reiterated Wednesday the urgent need for the administration and Congress to amend the proposed U.S.-Mexico-Canada Agreement (USMCA) to remove provisions that […]

CSRXP URGES HOUSE LAWMAKERS TO CONTINUE WORKING ACROSS PARTY LINES TO HOLD BIG PHARMA ACCOUNTABLE

10-16-2019 Press Release

Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas of Bipartisan Consensus For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday ahead of three legislative proceedings on drug pricing proposals scheduled for Thursday. The U.S. House Committee on […]

CSRxP Urges E&C Lawmakers to Continue Building Bipartisan Consensus

09-23-2019 Press Release

Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of Agreement to Hold Big Pharma Accountable and Lower Drug Prices  For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday ahead of a U.S. House Committee on Energy and Commerce Subcommittee on […]

CSRxP: House Rx Package Adds to Unprecedented Momentum to Hold Big Pharma Accountable

09-19-2019 Press Release

Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from Both Sides of the Aisle For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the release of details of a drug pricing plan circulated by U.S. House Speaker Nancy Pelosi […]

CSRxP: HHS OIG REPORT DRASTICALLY UNDERCUTS BIG PHARMA’S BLAME GAME AT CRITICAL MOMENT IN WASHINGTON

09-13-2019 Press Release

Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes, Saved Program $8 Billion on Drug Costs For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today following the release of a new report from the U.S. Department of Health & Human […]

NEW STUDY: BIG PHARMA PRICE-GOUGING MEDICATIONS FOR RARE DISEASES AT STAGGERING RATE

09-11-2019 Press Release

Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs, AHIP Finds For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today following the release of a new report from America’s Health Insurance Plans (AHIP) that found Big Pharma manipulated The Orphan Drug […]

CSRxP Commends Administration for Commitment to DTC Advertising Rule

08-21-2019 Press Release

Applauds HHS For Appealing Ruling Against List Price Transparency Measure   For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today after the U.S. Department of Health and Human services appealed a federal ruling blocking the implementation of a measure to require drug […]

Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game

08-16-2019 Press Release

Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums Down A new report from the Government Accountability Office (GAO) undermines a common refrain in Big Pharma’s blame game targeting pharmacy benefit managers (PBMs) and rebates. In an effort to distract from their own price-gouging and anti-competitive behavior, Big Pharma frequently […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.